Description

BACTILOC-DXL 200 TABLET

Introduction: BACTILOC-DXL 200 TABLET is a powerful antibiotic formulation that combines Cefpodoxime Proxetil & Dicloxacillin Extended Release to provide effective treatment for a wide range of bacterial infections. This combination enhances antibacterial efficacy, ensuring optimal results in managing infections caused by susceptible bacteria.

Composition: Each BACTILOC-DXL 200 TABLET contains:

• Cefpodoxime Proxetil – A third-generation cephalosporin antibiotic known for its broad-spectrum activity against gram-positive and gram-negative bacteria.
• Dicloxacillin Extended Release – A penicillin-class antibiotic with an extended-release formulation that ensures prolonged antibacterial action for better therapeutic outcomes.

Mechanism of Action:

• Cefpodoxime Proxetil works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death.
• Dicloxacillin Extended Release disrupts bacterial cell wall formation and provides sustained antibiotic action over an extended period, reducing the frequency of dosing.

Indications: BACTILOC-DXL 200 TABLET is indicated for the treatment of various bacterial infections, including:

• Respiratory tract infections (bronchitis, pneumonia)
• Skin and soft tissue infections
• Urinary tract infections
• Ear, nose, and throat infections (sinusitis, tonsillitis, pharyngitis)
• Bone and joint infections

Dosage and Administration:

• The dosage of Cefpodoxime Proxetil & Dicloxacillin Extended Release should be determined by a healthcare professional based on the severity of the infection.
• Generally taken orally, with or without food, as prescribed.
• It is crucial to complete the full course of antibiotics to prevent bacterial resistance.

Benefits of BACTILOC-DXL 200 TABLET:

• Dual-action of Cefpodoxime Proxetil & Dicloxacillin Extended Release for broad-spectrum bacterial coverage.
• Extended-release formulation of Dicloxacillin ensures sustained action and reduces dosing frequency.
• Effective against both gram-positive and gram-negative bacterial infections.
• Enhances patient compliance due to prolonged therapeutic effects.

Side Effects: Common side effects of Cefpodoxime Proxetil & Dicloxacillin Extended Release may include:

• Nausea, vomiting, and diarrhea
• Abdominal pain
• Skin rashes or allergic reactions
• Headache or dizziness
• Temporary changes in liver function tests

Precautions and Warnings:

• Patients allergic to cephalosporins or penicillins should avoid BACTILOC-DXL 200 TABLET.
• Use with caution in patients with kidney or liver impairment.
• Avoid alcohol consumption during treatment to prevent adverse reactions.
• If severe allergic reactions occur, discontinue use immediately and seek medical attention.

Drug Interactions:

• Avoid concurrent use with other antibiotics that interact with Cefpodoxime Proxetil & Dicloxacillin Extended Release.
• Antacids and proton pump inhibitors may reduce the effectiveness of Cefpodoxime Proxetil.
• Warfarin and other blood thinners may interact with the medication, requiring close monitoring.

Conclusion: BACTILOC-DXL 200 TABLET is an effective combination of Cefpodoxime Proxetil & Dicloxacillin Extended Release, making it a potent option for treating various bacterial infections. Its extended-release formulation ensures prolonged action, enhancing treatment efficacy and patient compliance. Always consult a healthcare provider before starting the medication to ensure proper usage and safety.

Keywords

Cefpodoxime Proxetil & Dicloxacillin Extended Release, Cefpodoxime Proxetil & Dicloxacillin Extended Release dosage, Cefpodoxime Proxetil & Dicloxacillin Extended Release uses, Cefpodoxime Proxetil & Dicloxacillin Extended Release benefits, Cefpodoxime Proxetil & Dicloxacillin Extended Release treatment, Cefpodoxime Proxetil & Dicloxacillin Extended Release infections, Cefpodoxime Proxetil & Dicloxacillin Extended Release for skin infections, Cefpodoxime Proxetil & Dicloxacillin Extended Release for respiratory infections, Cefpodoxime Proxetil & Dicloxacillin Extended Release side effects, Cefpodoxime Proxetil & Dicloxacillin Extended Release effectiveness, Cefpodoxime Proxetil & Dicloxacillin Extended Release precautions, Cefpodoxime Proxetil & Dicloxacillin Extended Release interactions, Cefpodoxime Proxetil & Dicloxacillin Extended Release antibiotic, Cefpodoxime Proxetil & Dicloxacillin Extended Release spectrum, Cefpodoxime Proxetil & Dicloxacillin Extended Release therapy, Cefpodoxime Proxetil & Dicloxacillin Extended Release clinical studies, Cefpodoxime Proxetil & Dicloxacillin Extended Release mechanism of action, Cefpodoxime Proxetil & Dicloxacillin Extended Release pharmacokinetics, Cefpodoxime Proxetil & Dicloxacillin Extended Release in pregnancy, Cefpodoxime Proxetil & Dicloxacillin Extended Release breastfeeding safety, Cefpodoxime Proxetil & Dicloxacillin Extended Release drug interactions, Cefpodoxime Proxetil & Dicloxacillin Extended Release renal dosing, Cefpodoxime Proxetil & Dicloxacillin Extended Release hepatic dosing, Cefpodoxime Proxetil & Dicloxacillin Extended Release antibiotic resistance, Cefpodoxime Proxetil & Dicloxacillin Extended Release indications, Cefpodoxime Proxetil & Dicloxacillin Extended Release patient care, Cefpodoxime Proxetil & Dicloxacillin Extended Release drug monitoring, Cefpodoxime Proxetil & Dicloxacillin Extended Release for ENT infections, Cefpodoxime Proxetil & Dicloxacillin Extended Release urinary tract infections, Cefpodoxime Proxetil & Dicloxacillin Extended Release bacterial infections, Cefpodoxime Proxetil & Dicloxacillin Extended Release extended-release advantages, Cefpodoxime Proxetil & Dicloxacillin Extended Release antibiotic combination, Cefpodoxime Proxetil & Dicloxacillin Extended Release effectiveness in pneumonia, Cefpodoxime Proxetil & Dicloxacillin Extended Release effectiveness in tonsillitis, Cefpodoxime Proxetil & Dicloxacillin Extended Release clinical trials, Cefpodoxime Proxetil & Dicloxacillin Extended Release pharmacodynamics, Cefpodoxime Proxetil & Dicloxacillin Extended Release overuse risks, Cefpodoxime Proxetil & Dicloxacillin Extended Release medical review, Cefpodoxime Proxetil & Dicloxacillin Extended Release effectiveness in bone infections, Cefpodoxime Proxetil & Dicloxacillin Extended Release pediatric use, Cefpodoxime Proxetil & Dicloxacillin Extended Release geriatric use, Cefpodoxime Proxetil & Dicloxacillin Extended Release antibiotic stewardship, Cefpodoxime Proxetil & Dicloxacillin Extended Release therapeutic use, Cefpodoxime Proxetil & Dicloxacillin Extended Release metabolism, Cefpodoxime Proxetil & Dicloxacillin Extended Release absorption, Cefpodoxime Proxetil & Dicloxacillin Extended Release overdose management, Cefpodoxime Proxetil & Dicloxacillin Extended Release contraindications, Cefpodoxime Proxetil & Dicloxacillin Extended Release clinical efficacy.